Zevra Therapeutics's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Zevra Therapeutics (NASDAQ:ZVRA) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.30. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $4.63 as of November 3, and over the last 52-week period, shares are down 19.33%.
November 06, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Zevra Therapeutics is expected to report an EPS of $-0.30 in its upcoming earnings report. The company's share price has historically been affected by its earnings reports. Over the past year, the share price has decreased by 19.33%.
The company's earnings report is a significant event that can impact its stock price. Given the estimated negative EPS and the historical pattern of share price changes following earnings reports, it is likely that the stock price may be negatively affected in the short term. Additionally, the overall negative return over the past year indicates a bearish sentiment among long-term shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100